5 Results for "

BLX

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "BLX" in MCE Product Catalog:

Cat. No.: HY-117317
CAS No.: 1080008-87-2
Target:  

Lipoxygenase

Research Areas:  

Inflammation/Immunology

BLX-2477 is a potent and selective 15-lipoxygenase-1 (15-LOX-1) inhibitor with an IC50 value of 99 nM. BLX-2477 can inhibit the generation of inflammatory lipid mediators such as 15-hydroxy-eicosatetraenoic acid (15-HETE). BLX-2477 can be used for the research of inflammation and immunology .
loading...
    loading...
Cat. No.: HY-P991548
CAS No.: 2170268-76-3

Target:  

CD20

Research Areas:  

Inflammation/Immunology Cancer

BLX-301 is a humanized monoclonal antibody targeting CD20. BLX-301 exhibits anti-tumor activity and can be used in the research of diseases such as non-Hodgkin lymphoma and rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-138154
CAS No.: 934758-70-0
Target:  

Lipoxygenase

Research Areas:  

Metabolic Disease

BLX-3887 is a selective 15-lipoxygenase type 1 (15-LO-1) inhibitor with an IC50 of 32 nM. BLX-3887 can be utilized in research related to the 15-LO pathways .
loading...
    loading...
Cat. No.: HY-148585
CAS No.: 2573048-10-7
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-22 is a BTK inhibitor (IC50: 0.9 nM). BTK-IN-22 also inhibits BLX and BMX with IC50s of 1.4 and 1.2 nM respectively. BTK-IN-22 shows improved kinase selectivity compared to Ibrutinib (HY-10997)
loading...
    loading...
Cat. No.: HY-148594
CAS No.: 2573048-11-8
Target:  

Btk

Research Areas:  

Cancer

BTK-IN-23 is a BTK inhibitor (IC50: 12.8 nM). BTK-IN-23 also inhibits BLX and BMX with IC50s of 35.6 and 5.7 nM respectively. BTK-IN-23 shows improved kinase selectivity compared to Ibrutinib (HY-10997) .
loading...
    loading...